I agree that this site is using cookies. You can find further informations here.
X
Schoser, B.
211  results:
Search for persons X
?
1

O21 104-week efficacy and safety of cipaglucosidase alfa+mi..:

Mozaffar, T. ; Bratkovic, D. ; Byrne, B....
Neuromuscular Disorders.  33 (2023)  - p. S191 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P319 Histopathological features and autophagy aspects of Ku..:

Preusse, C. ; Holzer, M. ; Schneider, U....
Neuromuscular Disorders.  33 (2023)  - p. S94 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P375 COMET: Safety of avalglucosidase alfa in patients with..:

Diaz-Manera, J. ; Kishnani, P. ; Ladha, S....
Neuromuscular Disorders.  33 (2023)  - p. S152 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P384 Mitochondrial dysfunction in myotonic dystrophy Type 2:

Kleefeld, F. ; Stenzel, W. ; Horvath, R...
Neuromuscular Disorders.  33 (2023)  - p. S154 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P373 Effect size analysis of cipaglucosidase alfa + miglust..:

Diaz-Manera, J. ; Bratkovic, D. ; Byrne, B....
Neuromuscular Disorders.  33 (2023)  - p. S151 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P376 COMET post hoc analysis: efficacy of long-term avalglu..:

Toscano, A. ; Kishnani, P. ; Dimachkie, M....
Neuromuscular Disorders.  33 (2023)  - p. S152 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P377 Patients in the Pompe registry who switched from alglu..:

Schoser, B. ; Toscano, A. ; Foster, M....
Neuromuscular Disorders.  33 (2023)  - p. S152 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P371 Switching treatment to cipaglucosidase alfa+miglustat ..:

Claeys, K. ; Byrne, B. ; Diaz-Manera, J....
Neuromuscular Disorders.  33 (2023)  - p. S151 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P374 COMET: effects of avalglucosidase alfa and treatment s..:

Kishnani, P. ; van der Beek, N. ; Haack, K An...
Neuromuscular Disorders.  33 (2023)  - p. S151-S152 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P 52 Short-term therapeutic effects of functional electrica..:

Mijic, M. ; Young, P. ; Schoser, B.
Clinical Neurophysiology.  137 (2022)  - p. e45 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Prinzipien der translationalen Gentherapie für neuromuskulä..:

Schoser, B.
Der Nervenarzt.  93 (2022)  6 - p. 537-548 , 2022
Link: https://doi.org/10.1007/..
 
?
12

FP.17 Long-term follow-up of cipaglucosidase alfa/miglustat..:

Schoser, B. ; Kishnani, P. ; Bratkovic, D....
Neuromuscular Disorders.  32 (2022)  - p. S73 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Clinical improvement of DM1 patients reflected by reversal ..:

van Cruchten, Remco T. P. ; van As, Daniël ; Glennon, Jeffrey C....
BMC Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
14

PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Func..:

Toscano, A ; van der Ploeg, AT ; Berger, KI...
Value in Health.  25 (2022)  12 - p. S403 , 2022
Link: https://doi.org/10.1016/..
 
?
15

P.025 Efficacy and safety results of the avalglucosidase al..:

Tarnopolsky, M ; Attarian, S ; Borges, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  48 (2021)  s3 - p. S27-S27 , 2021
Link: https://doi.org/10.1017/..
 
1-15